We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+14.65%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$10.2B
AUM Growth
+$1.36B
Cap. Flow
+$247M
Cap. Flow %
2.41%
Top 10 Hldgs %
41.78%
Holding
993
New
160
Increased
389
Reduced
300
Closed
137

Sector Composition

Rank Sector Weight
1 Energy 49.58%
2 Financials 10.59%
3 Technology 7.11%
4 Healthcare 5.04%
5 Industrials 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCKT icon
176
Rocket Pharmaceuticals
RCKT
$348M
$4.96M 0.05%
111,772
+12,019
+12% +$660K
MA icon
177
Mastercard
MA
$477B
$4.96M 0.05%
13,922
+5,138
+58% +$1.79M
XYZ
178
Block Inc
XYZ
$45.9B
$4.65M 0.05%
20,500
-1,080
-5% -$253K
AMSC icon
179
American Superconductor
AMSC
$1.48B
$4.62M 0.05%
243,760
+62,777
+35% +$1.55M
VCEL icon
180
Vericel Corp
VCEL
$2.3B
$4.62M 0.05%
83,143
+1,353
+2% +$61.2K
FIS icon
181
Fidelity National Information Services
FIS
$21.5B
$4.58M 0.04%
32,588
+2,554
+9% +$349K
GBT
182
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.56M 0.04%
111,795
+885
+0.8% +$40.7K
WLDN icon
183
Willdan Group
WLDN
$1.1B
$4.55M 0.04%
110,950
+28,667
+35% +$1.32M
XNCR icon
184
Xencor
XNCR
$1.44B
$4.51M 0.04%
104,828
+1,362
+1% +$64.5K
LGND icon
185
Ligand Pharmaceuticals
LGND
$6.02B
$4.43M 0.04%
46,623
+40
+0.1% +$3.78K
BSX icon
186
Boston Scientific
BSX
$65.8B
$4.3M 0.04%
111,149
-11,233
-9% -$425K
AMTX icon
187
Aemetis
AMTX
$119M
$4.07M 0.04%
+166,156
New +$1.86M
BX icon
188
Blackstone
BX
$104B
$4.04M 0.04%
54,250
-2,800
-5% -$193K
CNNE icon
189
Cannae Holdings
CNNE
$647M
$4.01M 0.04%
101,300
+19,425
+24% +$785K
AVGO icon
190
Broadcom
AVGO
$1.82T
$3.93M 0.04%
84,760
-12,810
-13% -$592K
BLUE
191
DELISTED
bluebird bio
BLUE
$3.62M 0.04%
9,270
+29
+0.3% +$14.3K
CRM icon
192
Salesforce
CRM
$134B
$3.6M 0.04%
17,008
+712
+4% +$159K
ETRN
193
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$3.54M 0.03%
434,455
+24,700
+6% +$188K
DRNA
194
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$3.53M 0.03%
138,074
+3,489
+3% +$89.1K
ORCL icon
195
Oracle
ORCL
$331B
$3.53M 0.03%
50,284
-6,799
-12% -$440K
INO icon
196
Inovio Pharmaceuticals
INO
$79.8M
$3.49M 0.03%
31,305
+6,072
+24% +$799K
GP
197
GreenPower Motor Co
GP
$10.5M
$3.46M 0.03%
13,902
+3,989
+40% +$1.09M
LLY icon
198
Eli Lilly
LLY
$1.07T
$3.44M 0.03%
18,411
-2,798
-13% -$547K
SUNW
199
DELISTED
Sunworks, Inc.
SUNW
$3.41M 0.03%
+232,545
New +$3.43M
MCRB icon
200
Seres Therapeutics
MCRB
$48M
$3.41M 0.03%
8,281
+771
+10% +$355K

Similar funds

ALPS Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, ALPS Advisors held 993 positions worth $10.2B, up 15% from $8.88B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

ALPS Advisors's Q1 2021 filing shows 160 new, 389 increased, 300 reduced and 137 closed positions. Its largest new stake was Array Technologies: 823,364 shares worth $24.6M. The largest sale was TC Pipelines LP, an estimated $179M.

By sector, the portfolio is most concentrated in Energy at 50% of assets, up from 48% a quarter earlier, followed by Financials and Technology.

  • ALPS Advisors's largest Q1 2021 buy was Array Technologies: 823,364 shares worth $24.6M.
  • ALPS Advisors added most to Magellan Midstream Partners, L.P. in Q1 2021, an estimated $70.7M increase.
  • ALPS Advisors's biggest Q1 2021 reduction was Caterpillar, cutting an estimated $40.8M.
  • ALPS Advisors fully exited TC Pipelines LP in Q1 2021, selling an estimated $179M.
  • ALPS Advisors's ten largest holdings make up 42% of its $10.2B portfolio in Q1 2021.
  • ALPS Advisors opened 160 new positions and closed 137 in Q1 2021.
  • ALPS Advisors's portfolio value rose 15% quarter-over-quarter to $10.2B.

Based on ALPS Advisors's 13F filing for Q1 2021, filed 7 May 2021.